IRIS
BRIGANTI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.885
NA - Nord America 5.103
AS - Asia 811
AF - Africa 117
OC - Oceania 61
SA - Sud America 56
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.039
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.007
SE - Svezia 3.609
IT - Italia 1.119
FI - Finlandia 394
IE - Irlanda 216
DE - Germania 203
CN - Cina 187
IN - India 160
ID - Indonesia 106
JP - Giappone 73
GB - Regno Unito 70
CA - Canada 58
IR - Iran 56
NL - Olanda 53
TR - Turchia 49
AU - Australia 46
FR - Francia 45
SG - Singapore 45
ES - Italia 39
NG - Nigeria 38
BR - Brasile 35
MX - Messico 28
HK - Hong Kong 23
RU - Federazione Russa 23
EG - Egitto 20
TW - Taiwan 16
PL - Polonia 15
GR - Grecia 13
TZ - Tanzania 11
VN - Vietnam 11
BE - Belgio 10
CH - Svizzera 10
NZ - Nuova Zelanda 10
PE - Perù 10
UA - Ucraina 10
DZ - Algeria 9
IL - Israele 9
KR - Corea 9
NO - Norvegia 9
PK - Pakistan 9
PH - Filippine 8
TH - Thailandia 8
IQ - Iraq 7
MY - Malesia 7
SA - Arabia Saudita 7
BD - Bangladesh 6
BG - Bulgaria 6
EU - Europa 6
GH - Ghana 6
LT - Lituania 6
PT - Portogallo 6
CM - Camerun 5
KE - Kenya 5
PG - Papua Nuova Guinea 5
CO - Colombia 4
CZ - Repubblica Ceca 4
HR - Croazia 4
HU - Ungheria 4
LK - Sri Lanka 4
MW - Malawi 4
PA - Panama 4
TN - Tunisia 4
CL - Cile 3
GN - Guinea 3
LB - Libano 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BO - Bolivia 2
BY - Bielorussia 2
CU - Cuba 2
GM - Gambi 2
JM - Giamaica 2
LR - Liberia 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
NP - Nepal 2
RE - Reunion 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
ZM - Zambia 2
AL - Albania 1
AM - Armenia 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PY - Paraguay 1
RS - Serbia 1
UY - Uruguay 1
Totale 12.039
Salva come PNG Salva come JPEG
Città #
Lawrence 1.713
Princeton 1.708
Helsinki 387
Milan 311
Ashburn 306
New York 295
Dublin 212
Shanghai 155
Pune 68
Rome 60
Los Angeles 44
Washington 43
Seattle 37
Borås 36
Turin 35
Florence 23
Bengaluru 21
Hanover 20
Sydney 20
Istanbul 19
Pekanbaru 18
Makassar 17
Palermo 17
Bologna 16
Jakarta 16
Oldenburg 16
Central 15
Paris 15
Rockville 15
Amsterdam 14
Lagos 13
Naples 12
West Jordan 12
Council Bluffs 11
Dar es Salaam 11
Genoa 11
Singapore 11
Tokyo 11
Abuja 10
Bari 10
Ho Chi Minh City 10
Perugia 10
Coslada 9
Hyderabad 9
Lima 9
Monterrey 9
Monza 9
Moscow 9
Padova 9
Redwood City 9
San Jose 9
Tehran 9
Barcelona 8
Boardman 8
Brisbane 8
Cairo 8
London 8
Mumbai 8
Vaprio d'Adda 8
Athens 7
Bergamo 7
Berlin 7
Bursa 7
Delhi 7
Kaohsiung City 7
Kebumen Satu 7
Montreal 7
Pavia 7
Accra 6
Bangkok 6
Castel Gandolfo 6
Chennai 6
Dronten 6
Fukushima 6
Isfahan 6
Kish 6
Mountain View 6
Nuremberg 6
Perth 6
Tel Aviv 6
Toronto 6
Treviso 6
Trieste 6
Uberaba 6
Ancona 5
Ankara 5
Brooklyn 5
Corinth 5
Falconara Marittima 5
Falls Church 5
Hong Kong 5
Lamezia Terme 5
Melbourne 5
Mexico City 5
Miami 5
Palencia 5
Pescara 5
Port Moresby 5
Santa Maria 5
Semarang 5
Totale 6.189
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 442
Benign Prostatic Hyperplasia and Its Aetiologies 313
Women's sexual dysfunction: a pathophysiological review 228
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study 67
A propensity score approach for treatment evaluation based on Bayesian Networks 46
FATTORI PREDITTIVI DI LINFORREA DOPO PROSTATECTOMIA RADICALE E LINFOADENECTOMIA PELVICA 45
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 43
Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. 41
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis 40
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 39
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 39
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 37
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation 36
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 31
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 31
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 31
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 28
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 28
Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients 27
A comparative review of apomorphine formulations for erectile dysfunction - Recommendations for use in the elderly 27
Pelvic lymph node dissection in prostate cancer 27
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient 27
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 26
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 26
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 26
Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study 25
QUALI SONO I PAZIENTI A RISCHIO DI RECIDIVA BIOCHIMICA DI CARCINOMA PROSTATICO OLTRE I 10 ANNI DI FOLLOW-UP DOPO PROSTATECTOMIA RADICALE? 25
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 24
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 24
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis 24
PRESENTAZIONE CLINICA DELLA INDURATIO PENIS PLASTICA NEI PAZIENTI AL DI SOTTO DEI 40 ANNI 24
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 23
Prediction of Sexual Function After Radical Prostatectomy 23
When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool 23
[11C]choline PET/CT for the detection of tumor recurrence in prostate cancer patients with PSA<1.5 ng/mL 23
Survival of contemporary patients with non-metastatic urachal vs. non-urachal adenocarcinoma of the urinary bladder 23
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 23
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 23
How to Select the Optimal Candidates for Renal Mass Biopsy 23
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 22
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 22
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 22
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 22
Biopsy Core Number Represents One of Foremost Predictors of Clinically Significant Gleason Sum Upgrading in Patients With Low-risk Prostate Cancer 22
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 22
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores 21
Radical prostatectomy for incidental (stage t1a-t1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence 21
Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization 21
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 21
Choosing the Best Candidates for Penile Rehabilitation after Bilateral Nerve-Sparing Radical Prostatectomy 20
A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation 20
L'INVASIONE ESCLUSIVA DEL COLLO VESCICALE DA CARCINOMA PROSTATICO NON DOVREBBE ESSERE CONSIDERATA COME STADIO PT4 20
External validation of the updated briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection 20
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 20
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 20
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 20
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 20
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 20
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 20
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 20
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 19
The Evolution of Staging of Lymph Node Metastases in Clinically Localized Prostate Cancer 19
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 19
ELETTROSTIMOLAZIONE INTRAOPERATORIA DEI NERVI CAVERNOSI CON ELETTRODI IMPIANTABILI 19
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 19
Safety and Early Oncologic Outcomes of Lung Resection in Patients with Isolated Pulmonary Recurrent Prostate Cancer: A Single-center Experience 19
ADC in the evaluation of side-specific extracapsular extension of prostate cancer: development and internal validation of a nomogram of clinical utility 19
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study 19
Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy 19
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? 19
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 19
Topical prilocaine-lidocaine cream combined with peripheral nerve block improves pain control in prostatic biopsy: results from a prospective randomized trial 18
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 18
PICCOLE MASSE RENALI: SORVEGLIANZA ATTIVA VS. NEFRECTOMIA 18
A risk calculator predicting recurrence in lymph node metastatic penile cancer 18
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 18
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 18
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 18
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 18
Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? 17
Erectile Function Outcome after Bilateral Nerve Sparing Radical Prostatectomy: Which Patients May Be Left Untreated? 17
IMPATTO DELLA CLIMACTURIA SULLA FUNZIONE ORGASMICA IN PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE RETROPUBICA NERVE SPARING BILATERALE 17
A critical analysis of Permixon (TM) in the treatment of lower urinary tract symptoms due to benign prostatic enlargement 17
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups 17
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration 17
The waiting time for prostate cancer treatment in Italy: analysis from the Pros-IT CNR study 17
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate 17
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 17
Reply by Authors 17
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 17
Correction to: Renal histology across the stages of chronic kidney disease (Journal of Nephrology, (2021), 34, 3, (699-707), 10.1007/s40620-020-00905-y) 17
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 16
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 16
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 16
Performance Characteristics of Computed Tomography in Detecting Lymph Node Metastases in Contemporary Patients with Prostate Cancer Treated with Extended Pelvic Lymph Node Dissection 16
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 16
Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up 16
Which patients are the best candidates for penile rehabilitation after bilateral nerve sparing radical prostatectomy? Retrospective analysis of a single centre series 16
[11C]CHOLINE PET/CT for Early Detection of Tumor in Prostate Cancer Patients with PSA Level Lower Than 1.5 NG/ML 16
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 16
Totale 3.218
Salva come PNG Salva come JPEG
Categoria #
all - tutte 254.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 254.319
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 0 4
2019/202085 39 3 1 3 28 3 0 1 5 2 0 0
2020/2021268 0 1 18 3 5 206 4 1 21 6 3 0
2021/20221.073 0 46 34 467 59 58 95 67 33 60 43 111
2022/20238.195 3.966 1.458 487 71 52 807 299 459 256 84 137 119
2023/20242.906 149 212 329 296 297 578 217 375 84 318 51 0
Totale 12.938